France · Biotechnology startup
France · Novexel
Novexel SA, a pharmaceutical company, engages in the discovery and development of antibacterial and antifungal agents to treat bacterial
Funding reportedLast round: Series B
What company datasets say Novexel raised
Funding, as reported
Reported in all118.6Min the source's currency
Rounds2
Last roundSeries B
Last round dateJan 2007
Investors listed10
How it ended, so far
Exit
ExitBuyerPriceWhen
Biotechnology in France
Startups like it
ValnevaSaint-herblain · founded 2013
AbivaxParis · founded 2013- Amolyt PharmaÉcully · founded 2015
GenSight BiologicsParis · founded 2012
AgronutrisSaint-orens-de-gameville · founded 2011
M2I Life SciencesSaint Cloud · founded 2012
CarbiosClermont-ferrand · founded 2011
Calida TherapeuticsParis · founded 2022
Is this your company?
Add your raise, your deck and your story, and put Novexel in front of investors. Or tell us what we have wrong.